›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:VENTANA PTEN (SP218) RxDx Assay
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
RocheType:
FDA Approved (PMA)
Related tests:
The VENTANA PTEN (SP218) RxDx Assay is a qualitative immunohistochemical assay intended to be used in the assessment of PTEN protein in prostate adenocarcinoma. The OptiView DAB IHC Detection Kit is used for staining on a BenchMark ULTRA instrument. The assay is indicated as an aid in identifying patients with prostate adenocarcinoma who may be eligible for treatment with TRUQAP in combination with abiraterone acetate in accordance with the approved therapeutic product labeling.
Cancer:
Hormone Sensitive Prostate Cancer
Gene:
PTEN (Phosphatase and tensin homolog)
PTEN (Phosphatase and tensin homolog)
Drug:
Truqap (capivasertib)
Method:
Immunohistochemical assay
Approvals
Date
Cancer
Gene
Biomarker
Drug
Approved by